Immatics Equity Warrants Exp 1 July 2025 IMTXW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11/25/22 EST
2.73quote price arrow down-0.22 (-7.46%)
Volume
903
52 week range
0.88 - 4.41
Loading...
  • Open2.86
  • Day High2.92
  • Day Low2.85
  • Prev Close2.95
  • 52 Week High4.41
  • 52 Week High Date09/09/22
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open2.86
  • Day High2.92
  • Day Low2.85
  • Prev Close2.95
  • 52 Week High4.41
  • 52 Week High Date09/09/22
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immatics Equity Warrants Exp 1 July 2025

 

Profile

MORE
Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned...
Address
Paul Ehrlich-Strasse 15
Tuebingen
72076
Germany